Hematologic and serum biochemical changes associated with Devil Facial Tumor Disease in Tasmanian Devils

被引:8
|
作者
Peck, Sarah [1 ,2 ]
Corkrey, Ross [3 ]
Hamede, Rodrigo [4 ]
Jones, Menna [4 ]
Canfield, Paul [1 ]
机构
[1] Univ Sydney, Fac Vet Sci, Sydney, NSW, Australia
[2] Dept Primary Ind Pk Water & Environm, Wildlife Management Branch, Hobart, Tas, Australia
[3] Univ Tasmania, Tasmanian Inst Agr, Hobart, Tas, Australia
[4] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia
关键词
Cancer; clinical pathology; Tasmanian Devil; wildlife; PLATELET ACTIVATION; THROMBIN; PAR1; SITE; RECEPTORS; CLEAVAGE;
D O I
10.1111/vcp.12391
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background: Devil Facial Tumor Disease (DFTD) is an infectious tumor causing significant population declines in wild Tasmanian Devils. While clinical assessment and pathology have been well reported for DFTD, there is a lack of information on hematologic and biochemical alterations associated with DFTD. Objectives: The purpose of the study was to determine hematologic and serum biochemical variation in healthy, wounded, and DFTD-affected Tasmanian Devils. Methods: Blood samples were collected from wild Tasmanian Devils at 5 sites in Tasmania. Hematology and clinical biochemistry variables were compared between clinically healthy, wounded, and DFTD-affected devils. Differences were also analyzed among stages of DFTD, including individuals pre- and postclinical signs developing, and between ulcerated and nonulcerated DFTD tumors. Results: Statistically significantly increased counts in WBC, neutrophils, and platelets, and concentration of fibrinogen, as well as decreased counts in lymphocytes, erythrocytes, and HGB concentration were observed in DFTD-affected devils compared to healthy devils. Activities of ALP, ALT, and GLDH, concentrations of sodium, potassium and albumin, and sodium-to-potassium ratio and albumin-to-globulin ratio were significantly lower, and AST activity was significantly higher in animals with DFTD when compared to clinically healthy animals. No significant differences were found among stages of DFTD or ulcerated and nonulcerated tumors. Conclusions: The differences in hematology and clinical chemistry variables in devils with DFTD compared to healthy devils are nonspecific and reflective of acute phase response and inflammation, and anemia of chronic disease. Similar changes are observed with wounds but to a lesser extent.
引用
收藏
页码:417 / 429
页数:13
相关论文
共 50 条
  • [1] Vincristine Chemotherapy Trials and Pharmacokinetics in Tasmanian Devils with Tasmanian Devil Facial Tumor Disease
    Phalen, David N.
    Frimberger, Angela
    Pyecroft, Stephen
    Peck, Sarah
    Harmsen, Colette
    Lola, Suzanneth
    Mattos, Beatriz de Mello
    Li, Kong M.
    McLachlan, Andrew J.
    Moore, Antony
    [J]. PLOS ONE, 2013, 8 (06):
  • [2] Doxorubicin and carboplatin trials in Tasmanian devils (Sarcophilus harrisii) with Tasmanian devil facial tumor disease
    Phalen, David N.
    Frimberger, Angela E.
    Peck, Sarah
    Pyecroft, Stephen
    Harmsen, Colette
    Lola, Suzanneth
    Moore, Antony S.
    [J]. VETERINARY JOURNAL, 2015, 206 (03): : 312 - 316
  • [3] The pathology of devil facial tumor disease (DFTD) in Tasmanian devils (Sarcophilus harrisii)
    Loh, R.
    Bergfeld, J.
    Hayes, D.
    O'Hara, A.
    Pyecroft, S.
    Raidal, S.
    Sharpe, R.
    [J]. VETERINARY PATHOLOGY, 2006, 43 (06) : 890 - 895
  • [4] Tasmanian Devil facial tumor disease
    Vanherberghen, M.
    Desmecht, D.
    [J]. ANNALES DE MEDECINE VETERINAIRE, 2007, 151 (02) : 107 - 111
  • [5] Isotopic niche variation in Tasmanian devils Sarcophilus harrisii with progression of devil facial tumor disease
    Bell, Olivia
    Jones, Menna E.
    Cunningham, Calum X.
    Ruiz-Aravena, Manuel
    Hamilton, David G.
    Comte, Sebastien
    Hamede, Rodrigo K.
    Bearhop, Stuart
    McDonald, Robbie A.
    [J]. ECOLOGY AND EVOLUTION, 2021, 11 (12): : 8038 - 8053
  • [6] Conservation Management of Tasmanian Devils in the Context of an Emerging, Extinction-threatening Disease: Devil Facial Tumor Disease
    Menna E. Jones
    Peter J. Jarman
    Caroline M. Lees
    Heather Hesterman
    Rodrigo K. Hamede
    Nick J. Mooney
    Dydee Mann
    Chrissy E. Pukk
    Jemma Bergfeld
    Hamish McCallum
    [J]. EcoHealth, 2007, 4 : 326 - 337
  • [7] Conservation management of tasmanian devils in the context of an emerging, extinction-threatening disease: Devil facial tumor disease
    Jones, Menna E.
    Jarman, Peter J.
    Lees, Caroline M.
    Hesterman, Heather
    Hamede, Rodrigo K.
    Mooney, Nick J.
    Mann, Dydee
    Pukk, Chrissy E.
    Bergfeld, Jemma
    McCallum, Hamish
    [J]. ECOHEALTH, 2007, 4 (03) : 326 - 337
  • [8] An Agent-based Model of the Impact of Devil Facial Tumor Disease on an Isolated Population of Tasmanian Devils
    Knadler, Charles E., Jr.
    [J]. AGENT-DIRECTED SIMULATION SYMPOSIUM 2012 (ADS 2012), 2012, 44 (01): : 9 - 16
  • [9] Hematologic and serum biochemical reference intervals for wild Tasmanian devils (Sarcophilus harrisii)
    Peck, Sarah
    Corkrey, Ross
    Hamede, Rodrigo
    Jones, Menna
    Canfield, Paul
    [J]. VETERINARY CLINICAL PATHOLOGY, 2015, 44 (04) : 519 - 529
  • [10] Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils
    Cesar Tovar
    Ruth J. Pye
    Alexandre Kreiss
    Yuanyuan Cheng
    Gabriella K. Brown
    Jocelyn Darby
    Roslyn C. Malley
    Hannah V. T. Siddle
    Karsten Skjødt
    Jim Kaufman
    Anabel Silva
    Adriana Baz Morelli
    Anthony T. Papenfuss
    Lynn M. Corcoran
    James M. Murphy
    Martin J. Pearse
    Katherine Belov
    A. Bruce Lyons
    Gregory M. Woods
    [J]. Scientific Reports, 7